Pranathmaka Ayurvedics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-06-2024
- Paid Up Capital ₹ 0.65 M
as on 26-06-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.36 Cr
as on 26-06-2024
- Satisfied Charges ₹ 1.70 Cr
as on 26-06-2024
- Revenue -76.01%
(FY 2020)
- Profit 19.95%
(FY 2020)
- Ebitda -27.32%
(FY 2020)
- Net Worth -34.83%
(FY 2020)
- Total Assets -0.10%
(FY 2020)
About Pranathmaka Ayurvedics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.65 M.
The company currently has active open charges totaling ₹3.36 Cr. The company has closed loans amounting to ₹1.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bindhu Baby, Bismi Aji, Joby James, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24233KL2012PTC031088
- Company No.
031088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Pathanamthitta, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pranathmaka Ayurvedics?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Joby James  | Director | 20-Aug-2019 | Current |
| Bindhu Baby | Director | 29-Mar-2019 | Current |
| Bismi Aji | Director | 29-Mar-2019 | Current |
| Anna John | Director | 20-Aug-2019 | Current |
| Regiputhenparambil Cherian | Director | 20-Aug-2019 | Current |
| Binu Baby | Whole-Time Director | 01-Jul-2021 | Current |
Financial Performance of Pranathmaka Ayurvedics.
Pranathmaka Ayurvedics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 76.01% decrease. The company also saw a substantial improvement in profitability, with a 19.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pranathmaka Ayurvedics?
In 2019, Pranathmaka Ayurvedics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Aug 2020 | ₹3.60 M | Open |
Others Creation Date: 18 Aug 2016 | ₹3.00 Cr | Open |
Central Bank Of India Limited Creation Date: 25 Jul 2014 | ₹1.70 Cr | Satisfied |
How Many Employees Work at Pranathmaka Ayurvedics?
Unlock and access historical data on people associated with Pranathmaka Ayurvedics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pranathmaka Ayurvedics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pranathmaka Ayurvedics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
